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 Abstract 
 Aim: This study aims to provide a brief questionnaire form of the Neuropsychiatric Inventory 
(NPI-Q) in Korean translated from the original NPI-Q that is intended for the evaluation of 
behavioral and psychological symptoms of dementia in routine clinical practice.  Patients and 
Methods: We developed a Korean version of the NPI-Q (KNPI-Q) and compared subitems 
with those of the Korean version of the NPI (KNPI) in 63 dementia patients; 47 patients had 
been diagnosed with Alzheimer’s disease with dementia, 8 with vascular dementia, and 8 with 
dementia with Lewy body disease. The diagnosis was based on the National Institute of Neu-
rological and Communicative Disorders and Stroke – Alzheimer’s Disease and Related Disor-
ders Association criteria for possible and probable Alzheimer’s disease and the  International 
Statistical Classification of Diseases and Related Health Problems , 10th revision, criteria for vas-
cular dementia and other dementing diseases. All patients received the Korean version of the 
Mini-Mental State Examination and the Clinical Dementia Rating within 1 month of the KNPI-
Q.  Results: Test-retest reliability of the KNPI-Q using a Pearson correlation index was r = 0.89 
for the total symptom scale and r = 0.90 for the distress scale. The prevalence of analogous 
symptom ratings differed by less than 6.7%. Convergent validity between the KNPI-Q and the 
NPI using a Pearson correlation index was r = 0.879 for the total symptom scale and r = 0.92 
for the distress scale.  Conclusions: The KNPI-Q is a reliable and brief instrument that can be 
employed for screening in the evaluation of neuropsychiatric symptoms of dementia and as-
sociated caregiver distress. It may be suitable for use in general clinical practice and could be 
administered as a brief neuropsychiatric interview.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
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 Introduction 
 Neuropsychiatric disturbances are common manifestations of all kinds of dementing 
disorders  [1] . The neuropsychiatric features of dementias have important diagnostic, prog-
nostic, and management implications  [2–4] . Neuropsychiatric symptoms may be the pre-
senting emerging manifestations before cognitive disturbance in dementia patients  [3] . 
Neuropsychiatric symptoms of dementia are distressing to patients and caregivers and 
often lead to institutionalization  [3, 5, 6] . The Neuropsychiatric Inventory (NPI) has been 
widely used for checking symptoms of neuropsychiatric disturbances  [1] ; with its proven 
validity and reliability, the NPI has been translated into many different languages, and its 
wide acceptance is evidenced by its use in a variety of dementia studies. The NPI assesses 
a broad range of psychopathologies through interviews with caregivers, who are familiar 
with patients’ behaviors. It encompasses 12 behavioral domains, with each domain con-
sisting of a screening question and 8 or 9 subquestions. Psychiatric symptoms of de-
mentia vary according to the study, population  [7] , cultural background  [8] , ethnicity  [8] , 
type of disease  [9] , and severity of dementia  [10] . One study reported that behavioral and 
psychological symptoms of dementia, in order of prevalence, were apathy, depression, irri-
tability, anxiety, and agitation, which were the most common symptoms occurring in very 
mild to mild Alzheimer’s disease patients in Korea  [11] . There is a need for methodologi-
cally similar and uniform studies of neuropsychological symptoms of dementia using appro-
priately validated instruments.
 The Korean version of the NPI (KNPI) was validated in 2000 by Choi et al.  [12] . It is a very 
delicate method used to assess dementia patients’ behaviors and burden. However, when 
patients have many behavioral and psychological symptoms, the test may take more than 20 
min to complete, which is impractical in many clinical settings. Instead, a caregiver-adminis-
tered NPI, in which caregivers complete the written form of the worksheet of the NPI, has 
been widely used in clinics  [13] . Still, this version also requires a significant time investment 
to complete.
 A brief version of the NPI, the NPI Questionnaire (NPI-Q), has been widely accepted as it 
saves time in general practice  [14] . The NPI-Q has already been validated and is widely used 
in many countries  [15–17] . The original version of the NPI-Q reported that test-retest reli-
ability of the NPI-Q was acceptable and that the prevalence of analogous symptoms reported 
on the NPI and the NPI-Q differed on average by 5%; moderate or severe symptom ratings 
differed by less than 2%  [14] . The purpose of this study was to evaluate the test-retest reli-
ability and convergent validity of the Korean version of the NPI-Q (KNPI-Q) and to compare 
it with the psychometric properties of the NPI in a practical setting. We will also discuss the 
relationship between the KNPI-Q, patients’ cognitive profiles and dementia severity. We 
hypothesized that the KNPI-Q presents psychiatric properties similarly to other language 
versions.
 Subjects and Methods 
 Participants 
 In total, 63 patients with dementia participated; 47 had been diagnosed with Alzheimer’s 
disease with dementia, 8 with vascular dementia, and 8 with dementia with Lewy body 
disease. The diagnosis was based on the National Institute of Neurological and Communi-
cative Disorders and Stroke – Alzheimer’s Disease and Related Disorders Association criteria 
for possible and probable Alzheimer’s disease  [18] and the  International Statistical Classifi-
cation of Diseases and Related Health Problems , 10th revision (ICD-10), criteria for vascular 
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dementia and other dementing diseases  [19] . Caregivers who provided behavioral infor-
mation were family members who lived with the patients or relatives who visited the patients 
more than twice per week.
 Translation of the KNPI-Q 
 The English version was translated into Korean by two Korean neurologists. The trans-
lated version went through two review processes, first by the behavioral neurology group 
and then by the 14 active members of the Korean Dementia Association. Further changes 
were made after it had been applied to 10 dementia patients. Then, the translated version
was translated back to English by a bilingual (a Korean-American) nonmedical person
who compared the original NPI-Q and the back-translated English version before deciding on 
the final KNPI-Q version.
 Administration of the KNPI-Q and KNPI 
 The KNPI-Q worksheet was graphically identical to the original NPI-Q version. Care-
givers of the patients were interviewed with the KNPI-Q using the same procedures as 
reported in the validation report of the original NPI-Q  [14] . Written instructions for 
completing the questionnaire form are included on the first page. Before giving the KNPI-Q 
worksheet to the caregivers, the examiners illustrated the procedure by offering examples 
in the delusion domain (presupervision). After the caregivers had completed the KNPI-Q 
without assistance, they were briefly interviewed by the examiner (postsupervision), a 
clinician who verified whether the caregivers had completed the form appropriately. We 
added a new item to the total score of the KNPI-Q, namely summation of severity × distress 
score, which differed from the original version. In the original version, the authors used a 
different symptom severity total score (0–36) and a total distress score (0–60). We analyzed 
the relationship between the total score of the KNPI-Q (0–144) and another set of scores 
(NPI severity, distress, and total scores).
 The NPI was administered so that its results could be compared to the KNPI-Q. The NPI 
was developed in a way that caregivers could complete the written form of the worksheet of 
the NPI with interviewer administration  [12] . The total score of the NPI was calculated by 
multiplying the frequency by the severity of each behavioral domain except for the caregiver 
distress score  [12] .
 The interview with the KNPI-Q was performed first to avoid bias against the KNPI. Test-
retest reliability was assessed by asking the caregivers to complete a blank KNPI-Q on the 
same day when arriving at home. The purpose of the test-retest administration was to 
examine how consistent the informants’ responses would be for the same assessment pe-
riod (the previous 4 weeks); therefore, a relatively short interval of several hours between 
administrations was used. The administration of the KNPI-Q preceded the administration 
of the KNPI by 7.3 ± 1.3 days (range 5–11). The majority (50 of 65) of participants received 
the tests on the same day. During the period between the administration of the KNPI-Q and 
the KNPI, drug dosages were not changed for patients prescribed medications for their 
behavioral symptoms. All patients received the Korean version of the Mini-Mental State 
Examination (K-MMSE)  [20] and the Clinical Dementia Rating (CDR)  [21] within 1 month of 
the KNPI-Q.
 Statistical Analysis 
 The Pearson correlation was applied to examine the test-retest reliability of the KNPI-Q 
scores. A nonparametric method, the Spearman correlation coefficient, was used to compare 
the scores of frequency and severity between the KNPI-Q and the KNPI.
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 Statement of Ethics 
 Confidentiality and anonymity of the participants were assured, and all participants 
provided informed consent together with their caregiver-informants as part of their evalu-
ation at Hanyang University Medical Center. The study received ethical approval by the In-
stitutional Review Board of Hanyang University Medical Center.
 Results 
 The demographics of patients and caregivers are presented in  table 1 . The participants 
consisted of 18 men and 45 women with a mean age of 78.9 ± 6.41 years (range 62–90), a 
mean education of 4.8 ± 5.16 years (range 0–16), a mean K-MMSE score of 15.61 ± 6.25 (range 
3–27), and a mean CDR score of 1.44 ± 0.73 (CDR score = 1 in 39 patients; CDR score = 2 in 
17 patients; CDR score = 3 in 7 patients) ( table 1 ). The caregivers included 12 men and 51 
women. Their mean age was 54.5 ± 10.9 years (range 32–86), and their mean education was 
8.1 ± 5.8 years (range 4–19). The KNPI-Q total symptom score was 9.39 ± 8.36 (range 0–25), 
and the caregiver distress score was 10.14 ± 10.19 (range 0–37) ( table 1 ).
 Test-retest reliability of the KNPI-Q using Pearson’s correlation index was r = 0.89 for the 
total symptom scale and r = 0.905 for the distress scale. The reliability (test-retest corre-
lation) of the total KNPI-Q severity and distress scales was 0.95 and 0.93, respectively (p < 
0.001 for both).
 The correlations of the subscale scores of each domain between the KNPI-Q and the KNPI 
are shown in  table 2 . The total symptom score (frequency × severity score) of the 12 neuro-
psychiatric domains obtained by the KNPI was compared to the severity scores obtained 
using the KNPI-Q ( table 2 ). The correlation coefficients showed a fair to good (r = 0.5–0.7) 
correlation of the severity score in all domains. The highest values were recorded for the 
delusion and dysphoria/depression items (r = 0.68 and 0.69, respectively) and the lowest 
value for the euphoria/elation item (r = 0.16). The distress score of the KNPI-Q was strongly 
correlated with that of the KNPI ( table 2 ). The correlation coefficients for distress were good 
to high (r = 0.63–0.81). The euphoria/elation and nighttime disturbance items had the lowest 
values (r = 0.57 and 0.54, respectively). The caregiver distress scores in each subscale of the 
KNPI-Q correlated significantly with those of the KNPI (all r > 0.54, p < 0.001;  table 2 ). The 




Age, years 78.9 ± 6.41 (62 – 90)
Education, years 4.8 ± 5.16 (0 – 16)
K-MMSE score 15.61 ± 6.25 (3 – 27)
CDR score 1.44 ± 0.73
KNPI-Q severity score 9.39 ± 8.36 (0 – 25)
KNPI-Q distress score 10.14 ± 10.19 (0 – 37)
KNPI-Q total score 20.5 ± 20.41
 KNPI total symptom score 20 ± 24 (0 – 144)
KNPI distress score 11.52 ± 12.67a
KNPI total score 20 ± 24 (0 – 144)
 Values are numbers or means ± standard deviations with ranges in 
parentheses. AD = Alzheimer’s disease; DLB = dementia with Lewy body 
disease; VD = vascular dementia. a Not included in total score.
 Table 1.  Participants’ 
characteristics
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p < 0.001;  table 2 ) except for the hallucination and euphoria/elation items (r = 0.30 and 0.40, 
respectively, p < 0.001;  table 2 ).
 To evaluate the usefulness of the KNPI-Q, we compared the symptom scores between the 
two scales according to the severity of dementia as reported in the original version of the 
NPI-Q  [14] . Fifty percent or more of all subjects had reported on both scales to have symptoms 
of apathy/indifference, dysphoria/depression, irritability/lability, and agitation. Hallucina-
tions, euphoria/elation, and appetite/eating disturbance were reported on both scales by less 
than or about 20% of subjects ( table 3 ). More patient symptoms were reported on the KNPI-Q 
(compared to the KNPI). Almost all domains were reported as 3.1–9.5% more prevalent on 
the KNPI-Q than on the KNPI except for agitation/aggression. Agitation/aggression was more 
prevalent on the KNPI than on the KNPI-Q. The prevalence of delusion, hallucination, anxiety, 
agitation/aggression, disinhibition, and appetite/eating disturbance differed by  ≤ 5% across 
the two scales. Euphoria/elation and nighttime disturbances differed in prevalence on the 
KNPI and KNPI-Q ( table 3 ). Overall, the average difference between the two scales for 
reporting a given symptom was 6.0% (mean absolute difference). The mean relative difference, 
reflecting the net difference in reported symptom prevalence, was 3.8%, with a higher mean 
for the KNPI-Q than for the KNPI. Moderate to severe delusion, agitation/aggression, disinhi-
bition, and appetite/eating disturbance were reported to be more prevalent on the KNPI, 
whereas moderate to severe hallucination, dysphoria/depression, apathy/indifference, irri-
tability/lability, aberrant motor behaviors, and nighttime disturbances were more commonly 
reported on the KNPI-Q ( table 3 ). Moderate to severe appetite/eating disturbance was more 
prevalent on the KNPI (by 4.7%). The mean absolute difference between the KNPI and the 
KNPI-Q in moderate to severe symptoms was 2 (3.1%).
 The correlation coefficient between the KNPI-Q total score and the KNPI was 0.98 regardless 
of the participants’ K-MMSE score ( table 4 ). When the participants were divided according to 
their K-MMSE score, the higher K-MMSE group had a better correlation between the KNPI-Q 
and the KNPI. In the high K-MMSE group, the KNPI-Q severity score presented a significant 
inverse correlation with the K-MMSE score ( table 4 ). This trend was not observed in the low 
K-MMSE group. The correlation coefficient of the KNPI-Q and KNPI total scores was 0.98 
regardless of the CDR score ( table 5 ). When the participants were divided according to the CDR 
score, the KNPI-Q score did not show any significant correlation with the CDR score ( table 5 ).
 Table 2. Interscale correlation between the KNPI-Q and the KNPI








Delusion 0.68* 0.76* 0.65* 0.59*
Hallucination 0.53* 0.73* 0.37* 0.30*
Agitation/aggression 0.52* 0.79* 0.72* 0.75*
Dysphoria/depression 0.69* 0.68* 0.70* 0.72*
Anxiety 0.64* 0.73* 0.65* 0.71*
Euphoria/elation 0.16 (p = 0.19) 0.57* 0.32* 0.40*
Apathy/indifference 0.58* 0.63* 0.59* 0.61*
Disinhibition 0.64* 0.81* 0.60* 0.59*
Irritability/lability 0.62* 0.80* 0.63* 0.67*
Aberrant motor behavior 0.66* 0.80* 0.68* 0.68*
Nighttime disturbance 0.50* 0.54* 0.64* 0.63*
Appetite/eating disturbance 0.51* 0.67* 0.56* 0.56*
* p < 0.0001, Spearman correlation coefficient.
219Dement Geriatr Cogn Disord Extra 2016;6:214–221
 DOI: 10.1159/000445828 
E X T R A
 Kim et al.: Validation Study of the Korean Version of the Brief Clinical Form of the 
Neuropsychiatric Inventory 
www.karger.com/dee
© 2016 The Author(s). Published by S. Karger AG, Basel
 Table 4. Interscale correlation between the KNPI-Q and the KNPI according to the K-MMSE
Variables High K-MMSE (>17) 
(n = 24)
Low K-MMSE (≤17) 
(n = 39)
KNPI-Q severity vs. KNPI total score 0.99* 0.80*
KNPI-Q distress vs. KNPI total score 0.87* 0.85*
KNPI-Q total vs. KNPI total score 0.98* 0.85*
KNPI-Q severity vs. K-MMSE –0.45 (p = 0.03) –0.12 (p > 0.05)
KNPI-Q distress vs. K-MMSE –0.18 (p > 0.05) 0.05 (p > 0.05)
KNPI-Q total score vs. K-MMSE 0.18 (p > 0.05) 0.08 (p > 0.05)
* p < 0.0001, Spearman correlation coefficient.
 Table 5. Interscale correlation between the KNPI-Q and the KNPI according to the CDR




KNPI-Q total vs. KNPI total score 0.98* 0.98* 0.99*
KNPI-Q distress vs. KNPI distress 0.77* 0.75* 0.80*
KNPI-Q severity vs. KNPI total symptom score 0.99* 0.99* 0.99*
KNPI-Q total vs. CDR 0.19 (p = 0.12) 0.10 (p = 0.54) 0.03 (p = 0.98)
KNPI-Q severity vs. CDR 0.22 (p = 0.08) –0.21 (p = 0.25) 0.33 (p = 0.04)
KNPI-Q distress vs. CDR 0.14 (p = 0.25) 0.29 (p = 0.09) 0.03 (p > 0.05)
* p < 0.0001, Spearman correlation coefficient.
 Table 3. Comparison of individual symptoms between the KNPI and the KNPI-Q (n = 63)
 Subjects with symptoms, n (%)











Delusion 21 (33) 24 (38)  + 3 (4.7) 14 (22) 13 (20) –1 (–1.5)
Hallucination 13 (20) 16 (25)  + 3 (4.7) 9 (14) 10 (15) +1 (1.5)
Agitation/aggression 34 (53) 32 (50)  – 2 (–3.1) 18 (28) 17 (27) –1 (–1.5)
Dysphoria/depression 34 (53) 38 (60)  + 4 (6.3) 20 (25) 22 (34) +2 (3.1)
Anxiety 28 (44) 30 (48)  + 6 (9.5) 20 (23) 20 (31) 0 (0.0)
Euphoria/elation 10 (16) 15 (24)  + 5 (8.0) 4 (6.3) 5 (7.9) +1 (1.5)
Apathy/indifference 29 (46) 33 (52)  + 4 (6.3) 21 (33) 22 (34) +1 (1.5)
Disinhibition 25 (40) 27 (43)  + 2 (3.1) 18 (28) 16 (24) –2 (–3.1)
Irritability/lability 28 (44) 32 (50)  + 4 (6.3) 20 (31) 21 (33) +1 (1.5)
Aberrant motor 23 (37) 27 (43)  + 4 (6.3) 20 (31) 21 (33) +1 (1.5) 
Nighttime disturbance 19 (30) 29 (46) +10 (15.8) 19 (25) 21 (33) +2 (3.1)
Appetite/eating disturbance 21 (33) 24 (38)  + 3 (4.7) 16 (25) 13 (20) –3 (–4.7)
a The mean absolute difference reflects the average difference between the scales in the number of reported symptoms for 
each domain. b Refers to symptom severity rating of either 2 (moderate) or 3 (severe).
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 Discussion 
 The KNPI-Q proved in many ways to be a very reliable and robust scale that required only 
a short time to complete; the mean time for completion was just 5 min. The reliability measures 
assessed in this study were also impressive. This study offers evidence that the KNPI-Q had 
adequate test-retest reliability and good correlation with the full version of the KNPI, espe-
cially with respect to the moderate to severe stage. This is a result similar to that of the 
original version of the NPI-Q  [14] .
 The KNPI-Q differs from the KNPI in some aspects. It is given as a two-page self-admin-
istered questionnaire and consists of symptom severity and caregiver distress ratings. The 
total score of the KNPI-Q is the result of the severity score multiplied by the caregiver distress 
scores. Compared with the KNPI, the results were statistically significant and correlated in 
each domain. In this study, the administration of the KNPI took a mean of 20 min. The KNPI 
was reported to take 20–30 min in a previous study  [12] . This result suggests that the KNPI-Q 
might be a good substitute for the KNPI or other tools since it can be completed by clinicians 
in a short period of time.
 The clinical validity of the scale must be considered sufficient. Most of the items of the 
KNPI-Q were highly correlated with items of the KNPI. However, the euphoria/elation items 
did not show a significant correlation with the original version on both the severity and 
distress scales. This finding might be due to difficulties in translating the definition of the item 
of euphoria/elation into Korean using a short sentence. A previous study about the neuropsy-
chiatric symptoms of Korean dementia patients showed a low prevalence of euphoria/elation 
 [11, 22] . In the original version of the NPI, euphoria/elation were the least prevalent neuro-
psychiatric symptoms of dementia  [1] . However, the severity scores were similar on the 
moderate to severe euphoria/elation item. That means it would be difficult to clarify this 
special symptom for caregivers of patients in a mild stage of dementia. Only a few participants 
reported that they experienced this problem in our study; this small number of answers could 
have influenced the statistically insignificant result of the correlation coefficient between the 
KNPI-Q and the KNPI. One other reason could be that caregivers might have different views 
and responses concerning the neuropsychiatric symptoms of dementia due to their race, 
culture, and ethnicity  [23] .
 When the KNPI-Q was analyzed after dividing the group according to the K-MMSE scores, 
it showed a good correlation with the KNPI in both groups. Only the severity score of the 
KNPI-Q was correlated with the K-MMSE in the high K-MMSE group; however, the total and 
the distress scores did not show a significant relation with the K-MMSE. When compared to 
the CDR score, there was also no correlation between the KNPI-Q and the CDR score. This 
finding is likely due to the diversity of the participants’ diseases.
 Conclusions 
 The KNPI-Q demonstrated an excellent correlation with the original KNPI and could be a 
good substitute in the clinic when only very short periods of time for evaluation are available. 
Therefore, the KNPI-Q can be used in clinical practice or research settings as a comprehensive, 
practical, reliable, and brief instrument to measure neuropsychiatric symptoms in patients 
with dementia and to assess the related emotional burden of primary caregivers.
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